Skip to content

Online parent-led treatment for obsessive-compulsive disorder in preadolescent children

Feasibility of a randomised controlled trial to compare an adapted online parent-led treatment to treatment as usual for preadolescent children with obsessive compulsive disorder (OCD)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12117573
Enrollment
48
Registered
2025-12-02
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Personality disorder - OCD

Interventions

Families taking part in the study will be randomly assigned to one of two groups: either the OSI for OCD intervention or treatment as usual (TAU) within mental health services that provide treatment o
>8 years), Gender and OCD symptom severity (measured by baseline CY-BOCS scores). We will use a randomisation tool that operates through a secure online platform, accessible only to authorised study p

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Child has been diagnosed with OCD on the basis of the ADIS-C or ADIS-P by the research team. 2. Parent/carer is willing and able to give informed consent for participation in the study on behalf of their child and themselves. 3. Child is willing and able to give informed assent for participation in the study. 4. Child aged 5–12 years. 5. Child has been referred to services that provide psychological support for child mental health problems on behalf of the NHS. 6. Child and parent/carer are able to understand, read, and communicate in English. 7. Parent/carer is willing and able to engage with the online intervention platform (OSI) if randomised to the OSI for OCD treatment arm. 8. Parent/carer is willing and able to complete required assessments.

Exclusion criteria

Exclusion criteria: 1. The child is currently receiving any other psychological intervention. 2. The child is receiving psychotropic medication and the dose has not been stable for at least two months. 3. The child has a confirmed or likely diagnosis of autism (indicated by a score > 15 on the Social Communication Questionnaire-lifetime version). 4. If the child has profound learning difficulties evidenced by attending a specialist school. 5. If there are risk and/or safeguarding concerns which are paramount and would interfere with treatment delivery, including suicidal intention, recurrent or potentially life-limiting self-harm, or if the child has a child protection plan/is on the child protection register/the research team consider the child to be suffering, or likely to suffer, significant harm. 6. Parent/carer or child is unable to understand, read, or communicate in English, which would prevent meaningful participation in the intervention or assessments. 7. The child is referred to a clinical team where the only usual treatment option is the University of Oxford’s face-to-face/telephone version of brief therapist guided, parent-led CBT for OCD

Design outcomes

Primary

MeasureTime frame
Trial feasibility measured using willingness of participants (parents and their children) to be randomised at throughout study;OCD symptom severity measured using Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) (parent and child report) at baseline, 20 weeks post randomisation, and 32 weeks post randomisation

Secondary

MeasureTime frame
1. Anxiety disorders and OCD are measured using the Anxiety Disorder Interview Schedule (ADIS-C and ADIS-P) at screening, 20 weeks post-randomisation, and 32 weeks post-randomisation 2. OCD symptom severity is measured using the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 3. OCD symptom severity is measured using the Obsessive Compulsive Inventory (OCI-CV-R) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 4. OCD symptom severity is measured using the Obsessional Compulsive Inventory (ChOCI-R-P) at baseline, at the start of each OSI-OCD module, and at 20 weeks and 32 weeks post-randomisation 5. Parental stress is measured using the Parental Stress Scale (PSS) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 6. Health-related quality of life for parents is measured using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 7. Health-related quality of life in children and young people is measured using the EuroQol 5-Dimension Youth 3-Level questionnaire (EQ-5D-Y-3L) and Child Health Utility 9D (CHU-9D) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 8. Health and social care resource use is measured using the Client Service Receipt Inventory (CSRI) at baseline, 20 weeks post-randomisation, and 32 weeks post-randomisation 9. Parents’ beliefs about treatment credibility and expectations of improvement are measured using the Credibility and Expectation of Improvement Scale – Parent report (CEI) immediately post-randomisation and at 20 weeks post-randomisation 10. Therapists’ beliefs about treatment credibility and expectations of improvement are measured using the Credibility and Expectation of Improvement Scale – Therapist report (CEI) immediately post-randomisation and at 20 weeks post-randomisation 11. Family accommodat

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026